Status:

COMPLETED

Virtual Reality Assisted CBT for Social Difficulties: a Feasibility Study in Early Intervention for Psychosis Services

Lead Sponsor:

King's College London

Conditions:

Psychosis

Social Behavior

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

People experiencing psychosis might find social interactions stressful and avoid them. This can result in isolation and can affect relationships, employment and quality of life. Improving social funct...

Detailed Description

Participants will be offered up to 10 sessions including a pre and post assessment session. Each participant will set one or more SMART goals for therapy (e.g. be able to use public transport, attend ...

Eligibility Criteria

Inclusion

  • The participant must be under the care of an approved research site throughout the period of the study i.e. local early intervention for psychosis clinical team
  • The participant must be aged 18-65 and speak English to a conversational level.
  • The participant must have experienced or currently be experiencing psychosis, as defined by ICD-10 and DSM-V criteria.
  • The participant must have the capacity to consent to the study
  • The participant should be experiencing difficulties in social situations (e.g. due to paranoia, social anxiety, poor social skills, low mood or lack of social motivation)

Exclusion

  • The participant must not have a history of epilepsy OR photosensitivity (any other comorbidity is fine).
  • The participant must not currently be in receipt of another psychological therapy at the time of the study (before or after the study is fine).

Key Trial Info

Start Date :

August 23 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2020

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04310475

Start Date

August 23 2019

End Date

October 1 2020

Last Update

April 8 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Psychiatry, Psychology and Neuroscience, King's College London

London, United Kingdom